55JL.Royal win Casino,100 free bonus casino no deposit GCash

<rt id="6qzad"><delect id="6qzad"><legend id="6qzad"></legend></delect></rt>

Covovax

Covid-19 vaccine for kids aged 5-12 years.(Representational image)

National

Covid Jab Covovax As Heterologous Booster To Be Available On CoWIN Soon; To Cost Rs 225 Per Dose

BY PTI

Only Covaxin To Be Administered To Children, Registrations On CoWIN From January 1, Health Ministry

National

Serum Institute Seeks Inclusion Of Covovax On CoWIN As Heterologous Booster Dose For Adults

BY PTI

Covid-19 vaccine for kids aged 5-12 years.(Representational image)

National

Covovax Booster Dose For Covid-19, Its Efficacy Rate And How Does It Work? All You Need To Know

BY Outlook Web Desk

?Representational Image

National

?DCGI Approves Market Authorisation For SII's Covid Vaccine Covovax As Heterologous Booster Dose

BY PTI

Covid-19 vaccine for kids aged 5-12 years.(Representational image)

National

DCGI Approves Market Authorisation For SII's Covid Vaccine Covovax As Heterologous Booster Dose

BY PTI

In India, SII makes the Covishield and plans to also make Covovax in collaboration with Novavax. Hyderabad-based Bharat Biotech manufactures the Covaxin vaccine.

National

Centre Recommends Covovax As Covid Booster Dose For Adults: Report

BY PTI

In Phase-3 Govt Recommends The Trial Of Covovax As Booster Dose In Adults(Representational image)

National

Government Panel Likely To Decide On Covovax As A Heterologous Booster Dose For Adults On Wednesday

BY PTI

Advertisement

Nationwide mock drill for COVID preparedness

National

Covid-19: Covovax To Get Approval As Booster In 10-15 Days, Says SII CEO Adar Poonawalla

BY PTI

In India, SII makes the Covishield and plans to also make Covovax in collaboration with Novavax. Hyderabad-based Bharat Biotech manufactures the Covaxin vaccine.

National

Serum Institute Seeks Drug Regulator's Approval For Market Authorisation Of Its Covid Vaccine As Booster Dose

BY PTI

Day After DCGI's Nod, SII Seeks Inclusion Of Covovax In Covid Immunisation Programme

National

Day After DCGI's Nod, SII Seeks Inclusion Of Covovax In Covid Immunisation Programme

BY Outlook Web Desk

DCGI Approves Indigenous mRNA Covid Jab For Emergency Use In 18 Years & Above; Covovax For 7-11 years

National

DCGI Approves Indigenous mRNA Covid Jab For Emergency Use In 18 Years & Above; Covovax For 7-11 years

DCGI To Review SII Application For Use Of Covovax Among Kids Aged 2-7 And 7-11

National

DCGI To Review SII Application For Use Of Covovax Among Kids Aged 2-7 And 7-11

BY PTI

Vaccines for teenagers.

National

Govt Panel Recommends Inclusion Of Covovax In National COVID-19 Vaccination Drive For Those Aged 12 And Above

BY Outlook Web Desk

Covovax reviewed for use in 12 year olds and above.

National

NTAGI's COVID Working Group To Review SII's Covovax Data For Use In 12 Year Olds And Above

BY Outlook Web Desk

Advertisement

In Phase-3 Govt Recommends The Trial Of Covovax As Booster Dose In Adults(Representational image)

National

Covid: Govt Panel Recommends Permission For Phase-3 Trial Of Covovax As Booster Dose In Adults

BY Outlook Web Desk

Representational Image

National

Govt Panel Recommends EUA For Covid Vaccine Covovax For 12-17 Age Group

BY PTI

Covid-19: Corbevax, Covovax Approval Brings Spotlight On India-US Collaboration

National

Covid-19: Corbevax, Covovax Approval Brings Spotlight On India-US Collaboration

BY Outlook Web Desk

Covovax approval to strengthen immunization efforts in India, lower- & middle-income countries: SII

National

Covovax approval to strengthen immunization efforts in India, lower- & middle-income countries: SII

BY Outlook Web Desk

Covid-19 Vaccines: Expert Panel Recommends EUA For Covovax, Corbevax & Molnupiravir Pills

National

Covid-19 Vaccines: Expert Panel Recommends EUA For Covovax, Corbevax & Molnupiravir Pills

BY Outlook Web Desk

<label id="fhxxe"><legend id="fhxxe"></legend></label>